Striving to become a world-class enterprise in aquatic disease prevention and control
Carp
Codfish
Carp
Carp
Codfish
Spring Viremia of Carp Virus (SVCV) is a highly pathogenic agent that severely affects cyprinid fish, belonging to the Rhabdoviridae family. It can lead to mortality rates as high as 90%. Currently, there are no effective therapeutic drugs available. Prevention relies solely on disinfection, inspection, and daily management measures. However, the subunit gene engineering immersion vaccine offers a safe, efficient, and scalable immunization solution for large-scale applications.
Carp Spring Viremia Virus Subunit Gene Engineering Vaccine Instruction Manual
Largemouth Black Bass Rhabdovirus (Micropterus Salmoides Rhabdovirus, MSRV) is a significant pathogen that endangers largemouth bass aquaculture, leading to high mortality rates. Traditional control methods (such as disinfection and immunostimulants) have limited effectiveness. Gene engineering subunit immersion vaccines represent a novel immunization strategy, offering advantages such as safety, high efficacy, and ease of operation. They are suitable for large-scale aquaculture immunization,, and can significantly reduce the economic losses caused by MSRV, promoting the sustainable development of the aquaculture industry.
Largemouth Bass Rhabdovirus Gene Engineering Subunit Vaccine Instruction Manual
Vaccine Antigen Preparation and Production
Loading the Vaccine onto Nanometer Materials
Soaking Immunity
Penetrating Fish Body, Internal Immunity
Harmless Discharge, Natural Degradation
Namibia Turns to
Vaccine Technology
Industry-Academia-Research Integration
Holistic Approach
Efficient Immunity
Solution
Carp
Chen Zhang, Gao-Xue Wang, Bin Zhu. Journal of nanobiotechnology.2020 18(1)
Nanometer vaccine for
aquatic diseases Can
significantly enhance the
fish's antibody efficacy level
Grass Carp
Bin Zhu, Chen Zhang, Zhao Zhao et al. Vaccines, 2020, 8(1).
Namirin vaccine for aquatic seedlings Can significantly enhance the fish's Antibody
level effectiveness
Grouper
Cao Yang, Liu-Long Wang, Xiang-Yu Qu et al Fish and Shellfish Immunology,2020,106.
Nano-antiviral agent for
aquatic vaccines Can
significantly enhance the fish body's Antibody efficacy level
Tilapia
Gao-Yang Liu, Jian Li, Zhong-Yu Zhang et al. Aquaculture 2021, 541
Namibia Tilapia Aquatic Vaccine
Can Significantly Enhance the Fish's
Antibody Efficacy Level
Sea Bass
Yi-Jun Jia, Zi-Rao Guo, Rui Ma et al. Fish and Shellfish Immunology,2020,100(c).
Namibia Tilapia Aquaculture Vaccine Can significantly enhance the fish body's Antibody titer level
Grass Carp
Zhong Yu Zhang, Gao Yang Liu, Rul Ma et al Fish and Shellfish Immunology.2020,97(c)
Namirui towards aquatic
vaccines Can significantly enhance the fish body's
Antibody level effectiveness
Eel
Zi-Rao Guo, Zhao Zhao, Chen Zhang et al. Fish and Shellfish Immunology,2020,99(prepublish)
Namibian tilapia aquaculture vaccine Significantly enhances the fish's Antibody efficacy level
Tilapia
Zhao Zhao, Chen Zhang, Yi-Jun Jila et al Fish and Shellfish Immunology,2019,92
Namibia Tilapia Aquatic Vaccine Can Significantly Enhance the Fish's Antibody Efficacy Level
Vincere is building a broad, high-quality, and differentiated product pipeline. Our portfolio of drugs in research and commercialized products is expected to cover 80% of cancer types (based on incidence rates). In addition to leveraging internal research resources, we are continuously evaluating external products in the pre-clinical and early clinical stages to further expand our product pipeline and strengthen our competitive advantage.
Wacosen possesses a comprehensive internal and external research and development platform, enabling products to be standardized, professional, and efficiently implemented.
Yang Ling Wankesen R&D Center
1. Genetic Engineering Research and Development Center
2. Nanomaterial Research and Development Center
3. Microbial Preparation Research and Development Center
4. Pest and Disease Diagnosis Research and Development Center
1. Aquatic Vaccine Research and Development Technology Platform
2. Aquatic Vaccine Technology Promotion Technology Platform
3. Aquatic Disease Detection and Diagnosis Technology Platform
4. Aquatic Animal Alternative Resistance Technology Platform
5. Comprehensive Environmental Management Technology Platform
Shenzhen Vancoresen Headquarters
Clinical Center
Marketing Department
Operations Center
Strategic Development Department
All rights reserved © Shenzhen Wankesen Biotechnology Co., Ltd.
Yue ICP Filing No. 2025457595-1
